Business Information
The group’s principle activity is to support the development and commercialization of cellular therapies. The group provides cGMP-compliant cell manufacturing and consulting services that address regulatory, financial, technical, process, and quality system strategies. The group’s services include a full spectrum of support and consulting related to process and product development, validation, due diligence evaluations, tissue collection, processing, and storage, product manufacturing, distribution and transportation. The group operates from United States.
|
|
Name |
Title
|
Email
|
| Andrew Pecora | Chmn., CEO, Chief Medical Officer, Member - Board of Mgr. | Available | | Robert Preti | Pres., Chief Scientific Officer, Dir., Mgr. | Available | | Stewart Craig | CTO, VP | Available | | Marie Devito | Sr. Dir. - Quality Assurance, Quality Control | Available | | Wai Chan | Scientific Dir. | Available
|
|
| Sales Range | Below 10 Millon | | Employee Range | 26 to 100 |
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
